Omega Funds Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
17

- Investments
-
214
- Portfolio
-
46
- Exits
-
135

Omega Funds General Information
Company Description
Founded in 2004, Omega Funds is a venture capital firm based in Boston, Massachusetts. The firm prefers to invest in the life sciences, digital health, immunology, rare diseases, precision medicine, oncology, cybersecurity, and software-as-a-service sectors. It is a Registered Investment Adviser (RIA).
Business Details
Website
www.omegafunds.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- 888 Boylston Street
- Suite 1111
- Boston, MA 02199
- United States
Omega Funds Investments (214)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Alleviant Medical | 17-Jan-2025 | Later Stage VC | Therapeutic Devices | Clinical Trials - General | ||
Windward Bio | 10-Jan-2025 | Drug Discovery | Startup | |||
Aviceda Therapeutics | 07-Jan-2025 | Biotechnology | Clinical Trials - Phase 2 | |||
Inmagene | 23-Dec-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
nChroma Bio | 05-Dec-2024 | Biotechnology | Generating Revenue | |||
Beta Bionics | 13-Nov-2024 | Therapeutic Devices | Generating Revenue/Not Profitable | |||
XII Medical | 21-Aug-2024 | Therapeutic Devices | Generating Revenue | |||
Catalym | 16-Jul-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
Scorpion Therapeutics | 16-Jul-2024 | Later Stage VC | Drug Discovery | Generating Revenue | ||
Third Arc Bio | 16-Jul-2024 | Early Stage VC | Biotechnology | Startup |
Omega Funds Exits (135)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Beta Bionics | 30-Jan-2025 | IPO | |
Chroma Medicine | 04-Dec-2024 | ||
Upstream Bio | 11-Oct-2024 | ||
Bicara Therapeutics | 13-Sep-2024 | ||
Morphic Therapeutic | 16-Aug-2024 | ||
EyeBio | 11-Jul-2024 | ||
Alumis | 28-Jun-2024 | ||
JenaValve Technology | 08-Apr-2024 | ||
Syros Pharmaceuticals | 19-Dec-2023 | Public Investment 2nd Offering | |
Alpine Immune Sciences | 06-Nov-2023 | Public Investment 2nd Offering |
Omega Funds Investments by Industry, Year, and Region
Omega Funds Co-Investors (211)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Janus Henderson Investors | 9 |
![]() |
![]() |
||
OrbiMed |
![]() |
![]() |
|||
Casdin Capital |
![]() |
![]() |
|||
The Invus Group |
![]() |
![]() |
|||
Wellington Management |
![]() |
![]() |
Omega Funds FAQs
-
What is Omega Funds?
Founded in 2004, Omega Funds is a venture capital firm based in Boston, Massachusetts.
-
When was Omega Funds founded?
Omega Funds was founded in 2004.
-
Where is Omega Funds headquartered?
Omega Funds is headquartered in Boston, MA.
-
What is Omega Funds's total asset value?
Omega Funds has around
in total assets under management. -
How many investments has Omega Funds made?
Omega Funds has made 214 investments.
-
What has Omega Funds invested in?
Omega Funds has made numerous investments in companies like Alleviant Medical, Windward Bio, and Aviceda Therapeutics within the Therapeutic Devices, Drug Discovery, and Biotechnology industries.
-
What has Omega Funds invested in recently?
Omega Funds's latest investment was on 17-Jan-2025 in Alleviant Medical, a company within the Therapeutic Devices industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »